The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors associated with overall survival in patients with melanoma leptomeningeal disease (M-LMD): A single institution retrospective review.
 
Karl Nyman
No Relationships to Disclose
 
Ronak Kundalia
No Relationships to Disclose
 
Oscar Ospina
No Relationships to Disclose
 
Gerald Carter Wallace
No Relationships to Disclose
 
Yolanda Pina
No Relationships to Disclose
 
Inna Smalley
Consulting or Advisory Role - LEK
Research Funding - Revolution Medicines (I)
Patents, Royalties, Other Intellectual Property - I have a patent pending related to the diagnostics of leptomeningeal disease. I am the inventor but I believe my institution holds the intellectual property rights (Inst)
 
Peter A. J. Forsyth
Honoraria - Abbvie; BTG; Novocure; Stanford University Health, Department of Neurology
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; BTG; Midatech Pharma; National Brain Tumor Society; Novartis; Novocure; Tocagen; ZIOPHARM Oncology
Research Funding - Bankhead-Coley Cancer Research; Bristol-Myers Squibb; Department of Defense; Florida Academic Cancer Center Alliance; Florida Breast Cancer Foundation; MSCCoE; NIH/NCI; Pfizer
Travel, Accommodations, Expenses - Abbvie; Bayer; Bristol-Myers Squibb; BTG; Inovio Pharmaceuticals; National Cancer Research Institute (NCRI); NCCN; NCI; NIH; Physical Sciences Oncology Network